???Exciting News from Philadelphia’s Biotech Scene!??? Tolerance Bio, a pioneering biopharmaceutical company based in Philadelphia, has secured $17.2 million in seed financing to advance their innovative thymus-based therapies for immune-related diseases. Join us in celebrating this achievement and the continued growth of our vibrant biotech community! ?? #GreaterPhiladelphia #Biotech #Innovation #LifeSciences #EconomicDevelopment #SelectGreaterPHL
We’re proud to announce the completion of a $17.2 million seed financing round. These funds will support advancing our thymus-based therapies, moving them towards clinical trials for the treatment of immune-mediated diseases caused by abnormalities in #immunetolerance such as cancer, autoimmunity, transplant rejection, and more. Learn more about the news and our commitment to making a meaningful impact in the lives of these patients: https://lnkd.in/dd2mtAzG ? #immunetolerance #thymushealth #thymus #diseaseprevention #celltherapy, #advancedtherapeutics #regenerativemedicine #longevity